SERIOUS
(G)
Actual Harm - a resident was hurt due to facility failures
Deficiency F0757
(Tag F0757)
A resident was harmed · This affected 1 resident
Based on record review and staff interview, it has been determined that the facility failed to ensure a resident's drug regimen is free from unnecessary drugs for 1 of 1 resident reviewed for adverse ...
Read full inspector narrative →
Based on record review and staff interview, it has been determined that the facility failed to ensure a resident's drug regimen is free from unnecessary drugs for 1 of 1 resident reviewed for adverse medication reactions, Resident ID # 36.
Findings are as follows:
Review of a facility policy titled, Allergy Notification dated 9/25/2018, states in part, Harmful unintended reactions to medicines, foods and to items in the environment are called adverse drug, food or environmental reactions or allergic reactions .To help ensure that adverse allergy reactions for a resident are not overlooked, the allergy design within the EMR [Electronic Medical Record] provides a structured format for users to document and monitor resident allergies .The allergies will be listed on the front cover of the medical record or computerized listing will be available in the medical record for reference .
Record review revealed that Resident ID #36 was admitted to the facility in December of 2022 with diagnoses including, but not limited to, history of urinary tract infections (UTIs) and dysuria (painful urination).
Review of a community report complaint received by the Rhode Island Department of Health on 9/21/2023 alleges that Resident ID #36 was treated with an antibiotic, Invanz (Ertapenem Sodium) for a UTI from 9/2/2023, 9/6/2023, and by 9/7/2023 the resident had confusion and hallucinations. Additionally, the allegation revealed that the resident had received the same antibiotic previously with a similar reaction of confusion and hallucinations. The antibiotic had not been added to the resident's allergy list to alert the provider or pharmacy of the adverse reaction.
Review of the Highlights of Prescribing Information for Invanz by Merck Pharmaceuticals revealed rare adverse reactions including, altered mental status, such as aggression, delirium, and hallucinations.
Review of the February 2023 Medication Administration Record (MAR) revealed the resident received INVanz Solution Reconstituted 1 GM [gram] (Ertapenem Sodium, antibiotic) Inject 1 gram intramuscularly [IM] one time a day for infection for 7 Days from 2/22-2/25/2023.
Review of the progress notes from February 2023 revealed the following:
2/23/2023 at 2:16 PM: .Pt [patient] shows apprehension towards IM antibiotic but allowed to be given on L [left] upper arm .
2/26/2023 at 2:09 AM: Socially Inappropriate/Disruptive: Noisiness/ Screaming. Resisted Care: Resisted ADL [activities of daily living] care. Paranoid Behaviors: Suspiciousness/ Fearfulness. Paranoid Behaviors: Hallucinations - Details of hallucinations: Seeing children in room. stated that they came out of [his/her] gut calling out names and yelling hello .
2/26/2023 at 5:33 AM: Pt refusing care this am. Insisting on sitting on side of bed. Demanding to get in chair but when approached to assist refuses assistance. Pt hallucinating 'bats all over [his/her] room and two babies sitting on the end of [his/her] bed .
2/26/2023 at 8:46 AM: Res [resident] continues with hallucinations this morning: Cats and dogs in room and two babies on the dresser. Called [sic] placed to covering MD [Medical Doctor], [name redacted], rec'd [received] n.o. [new order] .D/C'd [discontinued] Invanz.
2/27/2023 at 3:14 AM authored by the Physician, Staff C: Patient was reported to have some hallucination. Invanz IM discontinued .
Record review of the September 2023 MAR revealed the resident received INVanz Solution Reconstituted 1 GM (Ertapenem Sodium) Inject 1 gram intramuscularly in the morning for UTI for 5 Days from 9/2/2023 until 9/6/2023.
Review of the progress notes from September 2023 revealed the following:
9/8/2023 at 6:16 PM: Spoke with daughter [name redacted] about concerns of her [parent] being so confused and being alarmed there is no intervention being done about this.
9/10/2023 at 8:18 AM: Resident very restless, trying to get oob [out of bed] multiple times stating [s/he] wants to walk to the bathroom, also that [s/he] is going to the hospital for a test. staff tried to reorient and redirect [him/her] to stay in bed as [s/he] cannot ambulate the way [s/he] thinks [s/he] can, attempts unsuccessful.
9/11/2023 at 4:31 PM revealed that the nurse added Invanz to the resident's allergy list as the daughter indicated that the resident had a change in mental status after his/her last administration of the antibiotic.
During a surveyor interview on 9/21/2023 at 2:21 PM with the resident's daughter, she revealed that the resident was having hallucinations following the administration of the Invanz and that the same had occurred when s/he received the medication previously in February.
During a surveyor interview on 9/22/2023 at 9:55 AM with the resident, s/he revealed that s/he received an antibiotic to treat a urinary tract infection and it caused hallucinations. Additionally, s/he revealed that s/he had been told that the same reaction occurred when s/he took the same antibiotic at the beginning of the year.
During a surveyor interview on 9/22/2023 at 11:10 AM with Licensed Practical Nurse (LPN), Staff D, she revealed that the resident was on Invanz for a urinary tract infection and was having bizarre hallucinations such as, his/her grandchild being under his/her bed, talking to the ceiling and to people that were not there. Additionally, Staff D revealed that the resident appeared to be suffering severe mental anguish and distress. Staff D revealed that she had remembered this behavior occurred once before during another treatment (February) for a UTI and when she looked up the medication, [s/he] had also been on Invanz at that time
During a surveyor interview on 9/22/2023 at 10:44 AM with the Physician, Staff C, he revealed that he would not have ordered the same antibiotic if it had been marked on his/her medical record.
During a surveyor interview on 9/22/2023 at 10:57 AM with the Interim Director of Nursing Services (DNS) she was unable to provide evidence that the facility ensured a resident's drug regimen is free from unnecessary drugs by administering a medication with a known previous adverse reaction.
SERIOUS
(H)
Actual Harm - a resident was hurt due to facility failures
Quality of Care
(Tag F0684)
A resident was harmed · This affected multiple residents
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on record review, resident and staff interviews it has been determined that the facility failed to provide treatment and c...
Read full inspector narrative →
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on record review, resident and staff interviews it has been determined that the facility failed to provide treatment and care in accordance with professional standards of practice, the comprehensive person-centered care plan, and the residents' choices, for 1 of 1 resident reviewed for adverse medication reactions and following physicians' orders for specialist medical appointments, Resident ID #36 and 1 of 1 resident reviewed for Hospice Services, Resident ID #21.
Findings are as follows:
1a. Review of a facility policy titled, Allergy Notification dated 9/25/2018, states in part, Harmful unintended reactions to medicines, foods and to items in the environment are called adverse drug, food or environmental reactions or allergic reactions .To help ensure that adverse allergy reactions for a resident are not overlooked, the allergy design within the EMR [Electronic Medical Record] provides a structured format for users to document and monitor resident allergies .The allergies will be listed on the front cover of the medical record or computerized listing will be available in the medical record for reference .
Record review revealed that Resident ID #36 was admitted to the facility in December of 2022 with diagnoses including, but not limited to, history of urinary tract infections (UTIs) and dysuria (painful urination).
Review of a community report complaint received by the Rhode Island Department of Health on 9/21/2023 alleges that Resident ID #36 was treated with an antibiotic, Invanz (Ertapenem Sodium) for a UTI from 9/2/2023, 9/6/2023, and by 9/7/2023 the resident had confusion and hallucinations. Additionally, the allegation revealed that the resident had received the same antibiotic previously with a similar reaction of confusion and hallucinations. The antibiotic had not been added to the resident's allergy list to alert the provider or pharmacy of the adverse reaction.
Review of the Highlights of Prescribing Information for Invanz by Merck Pharmaceuticals revealed rare adverse reactions including, altered mental status, such as aggression, delirium, and hallucinations.
Review of the February 2023 Medication Administration Record (MAR) revealed the resident received INVanz Solution Reconstituted 1 GM [gram] (Ertapenem Sodium, antibiotic) Inject 1 gram intramuscularly [IM] one time a day for infection for 7 Days from 2/22-2/25/2023.
Review of the progress notes from February 2023 revealed the following:
2/23/2023 at 2:16 PM: .Pt [patient] shows apprehension towards IM antibiotic but allowed to be given on L [left] upper arm .
2/26/2023 at 2:09 AM: Socially Inappropriate/Disruptive: Noisiness/ Screaming. Resisted Care: Resisted ADL [activities of daily living] care. Paranoid Behaviors: Suspiciousness/ Fearfulness. Paranoid Behaviors: Hallucinations - Details of hallucinations: Seeing children in room. stated that they came out of [his/her] gut calling out names and yelling hello .
2/26/2023 at 5:33 AM: Pt refusing care this am. Insisting on sitting on side of bed. Demanding to get in chair but when approached to assist refuses assistance. Pt hallucinating 'bats all over [his/her] room and two babies sitting on the end of [his/her] bed .
2/26/2023 at 8:46 AM: Res [resident] continues with hallucinations this morning: Cats and dogs in room and two babies on the dresser. Called [sic] placed to covering MD [Medical Doctor], [name redacted], rec'd [received] n.o. [new order] .D/C'd [discontinued] Invanz.
2/27/2023 at 3:14 AM authored by the Physician, Staff C: Patient was reported to have some hallucination. Invanz IM discontinued .
Record review of the September 2023 MAR revealed the resident received INVanz Solution Reconstituted 1 GM (Ertapenem Sodium) Inject 1 gram intramuscularly in the morning for UTI for 5 Days from 9/2/2023 until 9/6/2023.
Review of the progress notes from September 2023 revealed the following:
9/8/2023 at 6:16 PM: Spoke with daughter [name redacted] about concerns of her [parent] being so confused and being alarmed there is no intervention being done about this.
9/10/2023 at 8:18 AM: Resident very restless, trying to get oob [out of bed] multiple times stating [s/he] wants to walk to the bathroom, also that [s/he] is going to the hospital for a test. staff tried to reorient and redirect [him/her] to stay in bed as [s/he] cannot ambulate the way [s/he] thinks [s/he] can, attempts unsuccessful.
9/11/2023 at 4:31 PM revealed that the nurse added Invanz to the resident's allergy list as the daughter indicated that the resident had a change in mental status after his/her last administration of the antibiotic.
During a surveyor interview on 9/21/2023 at 2:21 PM with the resident's daughter, she revealed that the resident was having hallucinations following the administration of the Invanz and that the same had occurred when s/he received the medication previously in February.
During a surveyor interview on 9/22/2023 at 9:55 AM with the resident, s/he revealed that s/he received an antibiotic to treat a urinary tract infection and it caused hallucinations. Additionally, s/he revealed that s/he had been told that the same reaction occurred when s/he took the same antibiotic at the beginning of the year.
During a surveyor interview on 9/22/2023 at 11:10 AM with Licensed Practical Nurse (LPN), Staff D, she revealed that the resident was on Invanz for a urinary tract infection and was having bizarre hallucinations such as, his/her grandchild being under his/her bed, talking to the ceiling and to people that were not there. Additionally, Staff D revealed that the resident appeared to be suffering severe mental anguish and distress. Staff D revealed that she had remembered this behavior occurred once before during another treatment (February) for a UTI and when she looked up the medication, [s/he] had also been on Invanz at that time
During a surveyor interview on 9/22/2023 at 10:44 AM with the Physician, Staff C, he revealed that he would have expected the staff to add the adverse medication reaction to the allergy list on the resident's face sheet. Additionally, he revealed that he would not have ordered the same antibiotic if it had been marked on his/her medical record.
During a surveyor interview on 9/22/2023 at 10:57 AM with the Interim Director of Nursing Services (DNS), she revealed that she would have expected the adverse medication reaction to be added to the allergy list, to alert the physician and pharmacy to not order it. Additionally, she was unable to provide evidence that the facility provided treatment and care in accordance with professional standards of practice by administering a medication with a known previous adverse reaction.
1b. Record review revealed a physician's order with a start date of 3/10/2023 for a urology consult due to recurrent urinary tract infections.
Review of a care plan for elimination revealed the resident has a history of UTIs with interventions including, but not limited to, urology consult as ordered.
Review of a progress note dated 3/14/2023 at 11:10 AM revealed an appointment scheduled for a urology consult for 4/13/2023.
Review of a progress note dated 4/5/2023 at 3:04 PM revealed the urology consult would be rescheduled to 6/26/2023.
Record review revealed a fax cover sheet from the urology provider that states, We have no record that [s/he] was seen 6/26/2023.
Record review failed to reveal evidence regarding the resident not attending his/her urology consult on 6/26/2023.
Record review of a Lab Results Report dated 9/1/2023, revealed the resident was positive for a UTI.
During a surveyor interview on 9/22/2023 at 10:44 AM with the Physician, Staff C he revealed that he was unaware that the resident did not attend his/her urology appointment and still wants the resident to have a urology consult.
During a surveyor interview on 9/22/2023 at 11:36 AM with a Receptionist at the urology provider, she revealed that the resident was a no call, no show for the appointment and that no one from the facility or family cancelled the appointment.
During a surveyor interview on 9/22/2023 at 10:57 AM with the Interim DNS, she was unable to provide evidence that the resident was seen by a urologist as ordered and per his/her care plan.
2. Record review revealed Resident ID #21 was admitted to the facility in March of 2020 with diagnoses including, but not limited to, unspecified dementia and generalized anxiety disorder.
Review of a Minimum Data Set (MDS) assessment dated [DATE] revealed a Brief Interview for Mental Status (BIMS) score of 9 out of 15, indicating moderately impaired cognition.
Record review revealed the resident was admitted to hospice services in November of 2021.
Review of the resident's care plan revealed a focus area dated 4/2/2020, which revealed the resident has the potential for mood alteration due to his/her diagnoses, and is evidenced by periodic tearfulness, anxious mood, restlessness, paranoid ideation, expressions of suicidal ideation or hopelessness, and medication refusals. Additionally, it was revised on 6/2/2023, to state, Ongoing anxious and restless mood observed. Not always easily redirected. Continue with current plan of care. Interventions include but are not limited to, document mood, behavior status, and changes to the physician as needed.
Review of the resident's progress notes revealed a note dated 8/29/2023 which states, Behavior: Pt [patient] awake most of the night, rang call bell approx 20 times during the night, repeated questions 'Am I gonna die', 'Am I gonna live', 'What tests are they running on me'. Intervention : Multiple attempts to answer pt's questions and offer reassurance. Brought pt several glasses of gingerale and adjusted bedding nurmerous [sic.] times. Pt denied pain/disc. Response : Behavior continued, pt seemed paranoid, anxious, stating 'Let me see your face, are you telling the truth? I see your eyes, I think that's a lie'.
Review of a document titled, HOSPICE CARE COORDINATION NOTE, dated 8/29/2023 states in part, .Spoke with .Floor staff who verbalize PT has been increasingly anxious, specifically at night where it keeps [him/her] up as [s/he] is fearful of dying in [his/her] sleep. Spoke with ADNS [Assistant Director of Nursing] who verbalized she is going to call MD [Medical Doctor] to reinstate Ativan [used to treat anxiety disorders] .
Further review of the HOSPICE CARE COORDINATION NOTE dated 8/29/2023 revealed a recommendation to restart Ativan 0.5 milligrams every 12 hours, as needed, for anxiety and agitation.
Further review of the resident's progress notes revealed a note dated 8/29/2023 which states, Resident seen by hospice RN [Registered Nurse] today. New recommendation to reinstate ativan 0.5mg [every 12 hours as needed] anxiety/agitation. ADON [Assistant Director of Nursing] reaching out to MD.
Record review failed to reveal evidence that the recommendation for Ativan was addressed or implemented by the physician.
Review of a behavior monitoring form dated 9/3/2023 at 8:55 PM, revealed the resident was displaying behavior symptoms such as, agitation restlessness, consistently picking or fidgeting with items or body parts, and repetitive babbling or perseverating on verbal phrases. It further revealed that non-pharmacological interventions were used, such as comfort visit and redirection, but were documented as being ineffective, with no change in behavior. Additionally, it revealed that no pharmacological intervention was used.
Review of an additional behavior monitoring form dated 9/13/2023, revealed the resident was displaying behavioral symptoms on 9/13/2023 at 3:30 AM. S/he displayed behaviors such as restlessness and agitation, evidenced by the resident ringing his/her call bell for approximately two hours. Potentially contributing factors were documented as increased anxiety. It further revealed that non-pharmacological interventions were used, such as comfort visit, food or drink offered, and toileting but was documented as being ineffective, with no change in behavior. Additionally, it revealed that no pharmacological intervention was used.
Review of the resident's behavior observation task revealed the following dates and times the resident displayed behaviors during the evening or night, following the recommendation for Ativan, such as verbal or physical aggression, social or sexually inappropriateness, withdrawn, anxiety, or refusal of care:
- 9/2/2023 at 8:43 PM, documented as occurring more than once during the shift
- 9/5/2023 at 9:37 PM, documented as occurring more than once during the shift
- 9/7/2023 at 8:32 PM, documented as occurring more than once during the shift
- 9/8/2023 at 8:52 PM, documented as occurring more than once during the shift
- 9/15/2023 at 8:21 PM, documented as occurring more than once during the shift
- 9/16/2023 at 7:41 PM, documented as occurring more than once during the shift
- 9/18/2023 at 8:04 PM, documented as occurring more than once during the shift
During a surveyor interview on 9/21/2023 at 10:23 AM, with LPN, Staff E, she revealed the resident is highly anxious and is very fixated on dying. She indicated these behaviors have been occurring for over a year and staff must constantly reassure him/her that death is not imminent.
During a surveyor interview on 9/21/2023 at 10:53 AM, with the Physician, Staff F, she revealed that hospice recommendations are reported to the physician by the nursing staff. She indicated that the resident has displayed these behaviors in the past, but revealed she was not aware that the behaviors have returned. Additionally, she was unable to provide evidence that the hospice recommendation was addressed.
During a surveyor interview on 9/21/2023 at 11:13 AM with the Interim DNS, she revealed that she was not aware of this recommendation and had not received it, prior to the surveyor bringing it to her attention. She further revealed that the resident and her family have refused Ativan in the past but was unable to provide evidence of any refusal or that the recommendation was addressed by the physician.
SERIOUS
(H)
Actual Harm - a resident was hurt due to facility failures
Deficiency F0697
(Tag F0697)
A resident was harmed · This affected multiple residents
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on surveyor observation, record review, resident, and staff interviews, it has been determined that the facility failed to...
Read full inspector narrative →
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on surveyor observation, record review, resident, and staff interviews, it has been determined that the facility failed to ensure that pain management was provided to a resident who required such services, consistent with professional standards of practice, the comprehensive person-centered care plan, and the resident's goals and preferences for 2 of 3 residents reviewed for pain management, Resident ID #s 46 and 257.
Findings are as follows:
Per the American Nurses Association (ANA) Statement The Ethical Responsibility to Manage Pain and the Suffering It Causes (2018): Nurses have an ethical responsibility to relieve pain and the suffering it causes; Nurses should provide individualized nursing interventions; The nursing process should guide the nurse's actions to improve pain management; Multimodal and interprofessional approaches are necessary to achieve pain relief .
Review of a facility provided policy titled Pain Management dated 2/3/2023 states in part, .If the resident's pain is not controlled by the current treatment regimen, the practitioner should be notified .
1. Record review for Resident ID #257 revealed s/he was admitted to the facility in September of 2023 with diagnoses including, but not limited to, osteomyelitis (bone infection), pressure ulcer of the sacral region stage 4 (stage 4 pressure ulcer is the most severe type of pressure ulcer. The skin is severely damaged, and the surrounding tissue begins to die. The underlying muscles or bone may also be damaged), pressure ulcer of the right buttocks stage 4, and pressure ulcer of the left buttocks stage 4.
Review of a Brief Interview for Mental Status conducted on 9/18/2023 revealed the resident scored a 15 out of 15 indicating the resident is cognitively intact.
Review of the care plan dated 9/14/2023 revealed the resident has pain or potential in an alteration in comfort related to a chronic physical disability, right hip infection, and pressure ulcers. It further has interventions which include, but are not limited to, report non-verbal or verbal signs and symptoms of pain promptly to the nurse, medicate prior to therapy and treatment procedures as needed, teach resident to request analgesics/non-pharmacological methods before pain becomes severe and clarify misconceptions about addictions to pain medications.
Review of the September 2023 Medication Administration Record (MAR) revealed the following orders:
-Oxycodone HCl tablet 5 milligram (MG) give 5 mg by mouth every 12 hours as needed for pain with a start date of 9/13/2023.
-Acetaminophen (Tylenol) tablet 325 MG give 2 tablets by mouth every 4 hours as needed for discomfort with a start date of 9/13/2023.
Record review failed to reveal a pain scale indicating when to administer each medication.
Review of occupational therapy documents dated 9/14/2023, revealed the residents pain limits his/her functional activities and s/he complained of 8 out of 10 pain to his/her right hip. It further revealed that the resident would like to be premedicated 1 hour prior to therapy related to his/her pain.
Review of the physical therapy documentation dated 9/18/2023 revealed that the resident's treatment was limited by 7 out of 10 right hip pain.
Review of the progress notes revealed the following:
-9/14/2023 at 2:44 PM .[complaint of] 7/10 [right] hip and lower back pain. Assessed by therapy today. Therapy recommends bed pump and scheduling oxycodone prior to [physical therapy] daily. OK'd by Dr .
-9/17/2023 at 11:53 PM authored by Registered Nurse (RN) Staff H, .Resident refused dressing changes this evening. Stated, 'I need to be medicated with oxycodone first so if you can't give me oxycodone then I'll wait till tomorrow when I can have some oxycodone before your [sic] change the dressings.' Unable to medicate resident with oxycodone [related to] time parameters .
-9/18/2023 at 7:45 AM authored by RN Staff I, .Pt. [patient] also questioning why Oxycodone order is [every] 12 [hours] as well. Pt. wants to take pain med before Therapy and prior to Dressing changes, however yesterday [s/he] [received] pain med [at] 10am [and] refused [dressing] changes on 3-11 shift because Oxycodone could not be admin. until 10pm. Pt. requesting to speak [with] Dr. [name redacted] regarding [his/her] medications. Advised to write down all [his/her] concerns so [s/he] will not forget any when speaking w/ Physician. Suggested to Pt. about administering Oxycodone [at] 6am, then [s/he] could have it again [at] 6pm before [dressing] changes. Pt. declined stating [s/he] wants to take 1 hour before Therapy. Pt. presently [complaint of] 8/10 post-op [right] hip pain, offered Tylenol 650mg and ice and agreeable, 0600am admin. Tylenol, reports Tylenol ineffective .
-9/18/2023 at 4:11 PM authored by the social worker Staff J, .Reports [his/her] concerns related to Oxycodone order, prefers every 6hrs [hours] vs 12hrs due to pain level throughout the day .
-9/18/2023 at 6:22 PM Facility spoke with the nurse practitioner regarding this resident's labs.
-9/19/2023 at 4:49 PM authored by the social worker Staff J, .patient requesting update on Oxycodone order. Writer explained this department would not be able to answer however as mentioned on 9/18, writer advised Nursing department this morning during morning report. Patient did not accept how the orders are handled within this facility and proceeded to refer to other hospitals/nursing facility standards. Patient expressed being dissatisfied with writer's answers. Writer attempted to advise again that the NP [Nurse Practitioner] will be in the facility on 9/20 and that she would be able to address concerns further .
Record review revealed that the facility contacted the provider on 9/18/2023 regarding lab results; however, they did not report the resident not getting his/her dressings changed due to pain.
Review of a pain interview completed on 9/19/2023 revealed that this resident had pain in the last 5 days. It further revealed that the pain is documented as occasionally. Additionally, the document revealed that pain has limited the resident's day to day activities. Lastly, at the time of the interview the resident's pain intensity was a 7 out of 10.
During a surveyor interview with the resident on 9/18/2023 at 12:15 PM, s/he revealed concerns related to medication management, specifically his/her oxycodone timing. The resident revealed that s/he is in pain often and specifically needs his/her oxycodone prior to therapy and dressing changes. S/he further stated staff told him/her to write down his/her concerns and to talk to the doctor on Wednesday 9/20/2023.
During a surveyor interview on 9/20/2023 at 9:07 AM with RN, Staff K, he revealed that the resident has osteomyelitis and skin grafts and that can be incredibly painful. He further revealed that he would not delay treatment saying to write something down on a Monday to be addressed on a Wednesday.
During a surveyor interview on 9/21/2023 at 8:30 AM with Staff I, she revealed that in report she was told on Sunday night 9/17/2023 the resident refused to have his/her dressing changes completed to his/her wounds due to pain and not having a pain medication available. She further revealed that on the morning of 9/18/2023 she advised the resident to write down all of his/her concerns so s/he could address them with the provider when she comes in. Lastly, she revealed she did not contact the physician related to the resident refusing the dressing changes due to pain.
During a surveyor interview on 9/22/2023 at 11:58 AM with RN, Staff H, she revealed that on 9/17/2023 she cared for the resident on the evening shift. She revealed that the resident wanted to be premedicated prior to his/her dressing changes. She indicated that when she checked the MAR the oxycodone was every 12 hours and told the resident to wait until 10 PM and then she could premedicate him/her to complete the dressings. The resident revealed that taking the medication at 10 PM and then completing the dressing changes would be too late. She further revealed that she did not contact the physician related to the resident's pain causing him/her to refuse the dressing changes.
During a surveyor interview with the Physician, Staff F, on 9/21/2023 at 10:29 AM, she revealed that the facility did not call her, or the on-call provider related to the pain the resident was experiencing. Additionally, she revealed that if the facility reaches out to providers related to pain, typically the on call provider will give a one time dose if needed. Lastly, she revealed she would have expected them to call and ask for a one-time dose on 9/17/2023 so the dressing change could be completed.
During a surveyor interview on 9/20/2023 at 1:42 PM, with the Interim Director of Nursing Services (DNS), she revealed that she would have expected the nursing staff to reach out to the provider to report the resident's pain and inability to complete the wound dressing due to pain. Furthermore, she was unable to provide evidence the facility provided pain management to a resident who required such services, consistent with professional standards of practice, the comprehensive person-centered care plan, and the resident's goals and preferences resulting in the resident not receiving care of his/her stage 4 pressure wound dressings on 9/17/2023.
2. Record review revealed that Resident ID #46 was admitted to the facility in May of 2022 with a diagnosis including, but not limited to, polyosteoarthritis (present when four or more joints in the body are painful and inflamed).
Review of a Minimum Data Set assessment dated [DATE] revealed a Brief Interview for Mental Status score of 12 out of 15, indicating moderate cognitive impairment. Additionally, it revealed that the resident complained of occasional pain rating his/her pain a 6 out of 10.
Review of a care plan dated 5/12/2022 revealed the resident has pain or has the potential for pain due to osteoarthritis. The care plan includes an intervention to report non-verbal or verbal signs and symptoms of pain promptly to the nurse and reassess and adjust plan to optimize pain relief as needed.
Review of a progress note dated 9/17/2023 at 11:55 AM revealed, signs and symptoms of severe pain starting at lower back and affecting hips and bilateral lower legs. Unable to tolerate HOB [head of bed] elevated and sitting up to transfer. Reports pain subsides when not moving. Medicated with ES [extra strength] Tylenol and tramadol. Son in to visit and expressed concern regarding past back surgeries and requesting XRAYs. Awaiting orders from on call .
Record review failed to reveal evidence of physician notification of increased pain.
During a surveyor interview on 9/21/2023 at 9:58 AM with the resident in the presence of his/her son, s/he continued to complain of lower back pain radiating to his/her legs.
During a surveyor interview on 9/21/2023 at 10:28 AM with Registered Nurse, Staff G, she revealed that the resident did complain of pain to his/her lower back that morning. Additionally, she revealed that she was unaware if x-rays had been performed or if the residents increased pain had been reported to the doctor.
Review of a progress note dated 9/21/2023 at 12:40 PM stated in part, This writer spoke with [Doctor]. Pain management regime reviewed, New orders obtained for Aspercreme Patch Daily x 2 weeks to lower back; Resident has previously reported c/o [complaint of] pain to lower back, good effect or PRN [as needed] tramadol given. New orders obtained for X-RAY Spine .
During a surveyor interview on 9/21/2023 at 1:01 PM with Licensed Practical Nurse (LPN), Staff D, revealed that the resident complained of increased pain on Sunday 9/17/2023 and stated that the pain was concerning. Additionally, she revealed that the resident was administered extra strength Tylenol without effect and Tramadol with little effect. Staff D, revealed that she did not report the change in pain to the doctor or request the x-rays that the resident and family requested.
During a surveyor interview on 9/22/2023 at 10:44 AM with the Physician, Staff C, he revealed that the staff had not called him on 9/17/2023 to report an increase in back pain causing difficulty sitting up or transferring, until 9/21/2023, 4 days following the initial complaint. He indicated he did not receive communication regarding increased pain.
During a surveyor interview on 9/21/2023 at 10:32 AM with the Interim DNS, she revealed that she would expect the nurse to call the doctor for new orders if a resident complains of increased pain. Additionally, she was unable to provide evidence that the facility provided pain management consistent with professional standards of practice and reporting a change in condition to the provider.
CONCERN
(D)
Potential for Harm - no one hurt, but risky conditions existed
Comprehensive Care Plan
(Tag F0656)
Could have caused harm · This affected 1 resident
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on surveyor observation, record review, and staff interview, it has been determined that the facility failed to provide ca...
Read full inspector narrative →
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on surveyor observation, record review, and staff interview, it has been determined that the facility failed to provide care in accordance with a resident's comprehensive care plan for 1 of 2 residents, Resident ID #30 relative to aspiration.
Findings are as follows:
Record review revealed the resident was admitted to the facility in May of 2019 with diagnoses including. but not limited to, dysphagia (difficulty in swallowing) and unspecified dementia with other behavioral disturbances.
Review of a Minimum Data Set assessment dated [DATE] revealed the resident requires extensive assistance of one staff member for eating. Additionally, it revealed the resident is totally dependent upon two staff members for transfers.
Review of the resident's comprehensive care plan revealed a focus area initiated on 5/29/2019 and revised 8/21/2023, which revealed the resident is at risk for alteration in nutrition related to mental status, advanced age, dysphagia, and weight loss history. It further revealed that interventions include but are not limited to, aspiration precautions and out of bed for meals as able.
Record review revealed the resident was being treated by speech therapy from 1/11/2023 to 1/25/2023, following a diagnosis of right lower lobe pneumonia, which was documented as potentially aspiration based.
Review of a document titled, Speech Therapy Discharge Summary, dated 1/27/2023, states in part, .Training in maintaining upright position in the Broda chair as wel [sic.] to minimize aspiration risk .Swallow Strategies/Positions: To facilitate safety and efficiency, it is recommended the patient use the following strategies and/or maneuvers during oral intake .upright posture during meals and upright posture for [greater than] 30 min after meals .
During a surveyor observation on 9/19/2023 at 9:10 AM, it was revealed the resident was in bed and was being assisted with eating breakfast by a Nursing Assistant (NA).
During a surveyor interview on 9/19/2023 at 9:14 AM with NA, Staff A, she indicated that she did not know the resident but was told to feed him/her by the nurse. She revealed she had not yet received her assignment or information on the patients she will be caring for during that shift.
During a surveyor interview on 9/19/2023 at 10:04 AM with Licensed Practical Nurse, Staff B, she indicated that she is aware that the resident should not be eating in bed, but revealed she told the NA to feed him/her in bed due to being short staffed.
During a surveyor interview on 9/20/2023 at 1:48 PM with the Interim Director of Nursing Services, she revealed the resident should be out of bed during meals, per his/her comprehensive care plan.
CONCERN
(D)
Potential for Harm - no one hurt, but risky conditions existed
Respiratory Care
(Tag F0695)
Could have caused harm · This affected 1 resident
Based on surveyor observation, record review, and staff interview, it has been determined that the facility failed to provide respiratory care consistent with professional standards of practice for 1 ...
Read full inspector narrative →
Based on surveyor observation, record review, and staff interview, it has been determined that the facility failed to provide respiratory care consistent with professional standards of practice for 1 of 1 resident reviewed for oxygen therapy, Resident ID #15.
Findings are as follows:
Record review revealed the resident was admitted to the facility in June of 2022 with a diagnosis including, but not limited to, left base infiltrate (viral infection that can cause abnormal substances to take residence in the respiratory system).
Review of the resident's care plan revised on 9/1/2023, revealed that the resident has an alteration in respiratory status relative to a left base infiltrate. Interventions include, but are not limited to, administer oxygen per doctor/nurse practitioner order, monitor respiratory status and adjust flow rate as ordered, monitor response and report changes as indicated, update physician and document on status as needed.
Record review revealed a physician's order dated 8/31/2023 for oxygen at 2 Liters (L) via nasal cannula (NC), as needed, for shortness of breath or an oxygen saturation less than 90%.
Record review of a progress note dated 9/11/2023 revealed, Activities came to nurses station to inform us that resident was very red and saying [s/he] couldn't breath and oxygen was off of [him/her]. I went and put it back on and took a set of vital signs .Oxygen increased to 3LNC since sats were at 89%. Will pass this on to evening nurse when she comes in shortly.
During surveyor observations of the resident on the following dates and times revealed s/he was receiving oxygen therapy through his/her nasal cannula at 3 liters per minute:
-9/18/2023 at 9:19 AM
-9/19/2023 at 2:14 PM
-9/20/2023 at 8:12 AM
-9/21/2023 at 9:39 AM
During a surveyor interview with Licensed Practical Nurse, Staff E, on 9/21/2023 at 9:40 AM, she acknowledged that the resident was receiving 3 liters of oxygen via nasal cannula. Additionally, she could not provide evidence that the physician or nurse practitioner was informed of the resident's need for increased oxygen.
During a surveyor interview on 9/21/2023 at 1:14 PM with Physician, Staff F, she revealed that she would expect the nurse to inform her or the nurse practitioner if there was a change in the resident's condition. Additionally, she acknowledged that she was unaware that the resident required 3 liters of oxygen and would expect herself and or the nurse practitioner to be notified.
During a surveyor interview with the Interim Director of Nursing Services on 9/21/2023 at 12:43 PM, she revealed she would expect the nurse to have called the physician with the resident's change in oxygen requirements.
CONCERN
(D)
Potential for Harm - no one hurt, but risky conditions existed
Deficiency F0804
(Tag F0804)
Could have caused harm · This affected 1 resident
Deficiency Text Not Available
Read full inspector narrative →
Deficiency Text Not Available
CONCERN
(D)
Potential for Harm - no one hurt, but risky conditions existed
Deficiency F0811
(Tag F0811)
Could have caused harm · This affected 1 resident
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on surveyor observation, record review, and staff interview, it has been determined that the facility failed to ensure tha...
Read full inspector narrative →
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on surveyor observation, record review, and staff interview, it has been determined that the facility failed to ensure that feeding assistants provide dining assistance only for residents who have no complicated feeding problems for 1 of 2 residents observed being assisted by feeding assistants, Resident ID #30.
Findings are as follows:
According to the State Operation Manual Appendix PP- Guidance to Surveyors for Long Term Care Facilities, last revised 2/3/2023 states in part, Paid feeding assistants- .§483.60(h)(2) Supervision. (i) A feeding assistant must work under the supervision of a registered nurse (RN) or licensed practical nurse (LPN) .§483.60(h)(3) Resident selection criteria. (i) A facility must ensure that a feeding assistant provides dining assistance only for residents who have no complicated feeding problems.(ii) Complicated feeding problems include, but are not limited to, difficulty swallowing, recurrent lung aspirations, and tube or parenteral/IV feedings .
Record review revealed the resident was re-admitted to the facility in September of 2021 with diagnoses including, but not limited to, Alzheimer's disease, adult failure to thrive, and dysphagia (difficulty swallowing).
Record review of the Quarterly Minimum Data Set (MDS) assessment dated [DATE] revealed the Brief Interview for Mental Status was unable to be completed due to severely impaired cognition. Further review of the MDS revealed that the resident requires extensive assistance of one staff member for eating.
Record review revealed a physician's order dated 8/16/2022 for a pureed texture (soft, blended, and or strained semi-liquid foods with a smooth consistency that require no chewing) diet with nectar thickened liquids (Nectar thick liquids are thicker than water, fall slowly from a spoon).
During a surveyor observation on 9/18/2023 at 12:23 PM, on the beach unit revealed Resident ID #30 who has a complicated feeding problem being assisted with his/her meal by Senior Activity Leader, Staff P, and was supervised by Activities Assistant, Staff Q. Further observation failed to reveal that a nurse was nearby for supervision.
During continuous surveyor observations on 9/18/2023 from 12:23 PM to 12:48 PM Staff P was observed assisting Resident ID #30 without a nurse in the vicinity.
During the competent nurse staffing task, on 9/19/2023 at 12:26 PM with the Administrator and Infection Preventionist, they revealed that only one staff member, Staff Q, has completed all required training and is certified as a feeding assistant. They further revealed that the residents who are being assisted by the paid feeding assistants should not be assisted with eating outside of a nurses line of sight.
During a surveyor interview with the Administrator on 9/21/2023 at approximately 2:20 PM she failed to provide evidence that the facility ensured that fully trained paid feeding assistants are utilized during meals per the regulation.
CONCERN
(D)
Potential for Harm - no one hurt, but risky conditions existed
Medical Records
(Tag F0842)
Could have caused harm · This affected 1 resident
Based on record review and staff interview, it has been determined that the facility failed to maintain medical records in accordance with professional standards and practices for 1 of 1 resident revi...
Read full inspector narrative →
Based on record review and staff interview, it has been determined that the facility failed to maintain medical records in accordance with professional standards and practices for 1 of 1 resident reviewed for adverse medication reactions, Resident ID # 36.
Findings are as follows:
Record review revealed that Resident ID #36 was admitted to the facility in December of 2022 with diagnoses including, but not limited to, history of urinary tract infections (UTIs) and dysuria (painful urination).
Review of a community report complaint received by the Rhode Island Department of Health on 9/21/2023 alleges that Resident ID #36 was treated with an antibiotic, Invanz (Ertapenem Sodium) for a UTI from 9/2/2023, 9/6/2023, and by 9/7/2023 the resident had confusion and hallucinations. Additionally, the allegation revealed that the resident had received the same antibiotic previously with a similar reaction of confusion and hallucinations. The antibiotic had not been added to the resident's allergy list to alert the provider or pharmacy of the adverse reaction.
Review of the Highlights of Prescribing Information for Invanz by Merck Pharmaceuticals revealed rare adverse reactions including, altered mental status, such as aggression, delirium, and hallucinations.
Review of the February 2023 Medication Administration Record (MAR) revealed the resident received INVanz Solution Reconstituted 1 GM [gram] (Ertapenem Sodium, antibiotic) Inject 1 gram intramuscularly [IM] one time a day for infection for 7 Days from 2/22-2/25/2023.
Review of the progress notes from February 2023 revealed the following:
2/23/2023 at 2:16 PM: .Pt [patient] shows apprehension towards IM antibiotic but allowed to be given on L [left] upper arm .
2/26/2023 at 2:09 AM: Socially Inappropriate/Disruptive: Noisiness/ Screaming. Resisted Care: Resisted ADL [activities of daily living] care. Paranoid Behaviors: Suspiciousness/ Fearfulness. Paranoid Behaviors: Hallucinations - Details of hallucinations: Seeing children in room. stated that they came out of [his/her] gut calling out names and yelling hello .
2/26/2023 at 5:33 AM: Pt refusing care this am. Insisting on sitting on side of bed. Demanding to get in chair but when approached to assist refuses assistance. Pt hallucinating 'bats all over [his/her] room and two babies sitting on the end of [his/her] bed .
2/26/2023 at 8:46 AM: Res [resident] continues with hallucinations this morning: Cats and dogs in room and two babies on the dresser. Called [sic] placed to covering MD [Medical Doctor], [name redacted], rec'd [received] n.o. [new order] .D/C'd [discontinued] Invanz.
2/27/2023 at 3:14 AM authored by the Physician, Staff C: Patient was reported to have some hallucination. Invanz IM discontinued .
Record review failed to reveal evidence that the Invanz was added to the resident's medical record after the resident experienced an adverse drug reaction.
Record review of the September 2023 MAR revealed the resident received INVanz Solution Reconstituted 1 GM (Ertapenem Sodium) Inject 1 gram intramuscularly in the morning for UTI for 5 Days from 9/2/2023 until 9/6/2023.
Review of the progress notes from September 2023 revealed the following:
9/8/2023 at 6:16 PM: Spoke with daughter [name redacted] about concerns of her [parent] being so confused and being alarmed there is no intervention being done about this.
9/10/2023 at 8:18 AM: Resident very restless, trying to get oob [out of bed] multiple times stating [s/he] wants to walk to the bathroom, also that [s/he] is going to the hospital for a test. staff tried to reorient and redirect [him/her] to stay in bed as [s/he] cannot ambulate the way [s/he] thinks [s/he] can, attempts unsuccessful.
9/11/2023 at 4:31 PM revealed that the nurse added Invanz to the resident's allergy list as the daughter indicated that the resident had a change in mental status after his/her last administration of the antibiotic.
During a surveyor interview on 9/21/2023 at 2:21 PM with the resident's daughter, she revealed that the resident was having hallucinations following the administration of the Invanz and that the same had occurred when s/he received the medication previously in February.
During a surveyor interview on 9/22/2023 at 9:55 AM with the resident, s/he revealed that s/he received an antibiotic to treat a urinary tract infection and it caused hallucinations. Additionally, s/he revealed that s/he had been told that the same reaction occurred when s/he took the same antibiotic at the beginning of the year.
During a surveyor interview on 9/22/2023 at 11:10 AM with Licensed Practical Nurse (LPN), Staff D, she revealed that the resident was on Invanz for a urinary tract infection and was having bizarre hallucinations such as, his/her grandchild being under his/her bed, talking to the ceiling and to people that were not there. Additionally, Staff D revealed that the resident appeared to be suffering severe mental anguish and distress. Staff D revealed that she had remembered this behavior occurred once before during another treatment (February) for a UTI and when she looked up the medication, [s/he] had also been on Invanz at that time. Staff D was unable to provide evidence that the resident's medical record was updated in February 2023 as s/he experienced an adverse drug reaction to Invanz.
During a surveyor interview on 9/22/2023 at 10:44 AM with the Physician, Staff C, he revealed that he would not have ordered the same antibiotic if it had been marked on his/her medical record.
During a surveyor interview on 9/22/2023 at 10:57 AM with the Interim Director of Nursing Services (DNS) she was unable to provide evidence that the facility updated the resident's medical record after the s/he experienced an adverse drug reaction in February 2023.
CONCERN
(D)
Potential for Harm - no one hurt, but risky conditions existed
Infection Control
(Tag F0880)
Could have caused harm · This affected 1 resident
Based on surveyor observation, record review, and staff interview, it has been determined that the facility failed to maintain an infection prevention and control program to help prevent the transmiss...
Read full inspector narrative →
Based on surveyor observation, record review, and staff interview, it has been determined that the facility failed to maintain an infection prevention and control program to help prevent the transmission of communicable diseases and infections for 1 of 1 resident reviewed for Methicillin-Resistant Staphylococcus Aureus (MRSA, an infection is caused by a type of staph bacteria that's become resistant to many of the antibiotics) and Clostridium difficile (C-diff), is a bacterium that is well known for causing serious diarrheal infections), Resident ID #257.
Findings are as follows:
Review of a facility policy titled Transmission Based Precaution Levels (Type of Infectious Conditions, Techniques and Documentation) dated 7/6/2022 states in part, POLICY: Regulatory and Centers for Disease Control (CDC) guidelines will be followed for the care of resident's requiring transmission-based precautions .Contact precautions [Wear a gown and gloves for all interactions that may involve contact with the resident or the resident's environment]: will be used for patients/resident [sic] who are known or suspected to have serious illnesses easily transmitted by direct resident/patient contact or by contact with items in the patients environment .
a. Review of the CDC Type and Duration of Precautions Recommended for Selected Infections and Conditions last revised on July 22, 2019, revealed Multidrug-resistant organisms (MDROs), infection or colonization (e.g., MRSA) require contact and standard with no end for duration recommended.
Record review revealed that Resident ID #257 was admitted to the facility in September of 2023 with diagnoses including, but not limited to, MRSA in his/her nares and osteomyelitis (bone infection).
Record review of the hospital Continuity of Care Form (COC) dated 9/9/2023 revealed that the resident was positive for colonized MRSA (MRSA colonization is when bacteria reside on an individual, but there are no signs or evidence of infection. An individual with colonized MRSA bacteria is called a MRSA carrier, they can transmit MRSA to others) on 9/9/2023 and was started on Bactroban (a medication to treat/decolonize a resident with MRSA in the nares or decolonized MRSA) twice daily for 4 days.
Review of the September 2023 Medication Administration Record (MAR) revealed the resident was receiving the Bactroban while at the facility for MRSA.
During a surveyor observation on 9/18/2023 it was revealed the resident was on contact precautions.
During a surveyor observation on 9/19/2023 it was revealed the resident was no longer on contact precautions.
During a surveyor interview on 9/19/2023 at 1:10 PM with Licensed Practical Nurse, Staff E, she revealed the resident had completed their Bactroban treatment and was removed from contact precautions.
Review of the CENTER FOR EPIDEMIOLOGY & INFECTIOUS DISEASES Guidelines for the Management of Methicillin Resistant Staphylococcus aureus in Rhode Island Long-Term-Care Facilities (2007) revealed that routine decolonization for MRSA in the nares is not recommended for long term care facility residents. It further revealed that decolonization attempts would be appropriate for residents admitted from the hospital with decolonization procedures already underway. Additionally, to remove a resident from contact precaution following decolonization would require the following criteria to be met: Contact precautions may be discontinued when there is documentation of two (2) consecutive negative MRSA screens from previously positive sites. Screens should be obtained no sooner than 72 hours after completion of decolonization and/or treatment of infection and screens should be at least 5 days apart.
During a surveyor interview on 9/21/2023 at 10:03 AM with the Infection Preventionist, she acknowledged the resident began decolonization in the hospital with Bactroban and continued with the decolonization once s/he entered the facility. She further acknowledged that the resident was not on precautions after 9/18/2023. Additionally, she acknowledged that the resident did not have the required decolonization testing completed as mentioned above for the contact precautions to be removed.
b. Review of the CDC Type and Duration of Precautions Recommended for Selected Infections and Conditions last revised on July 22, 2019, revealed Clostridium difficile (see Gastroenteritis, C. difficile) require contact and standard precautions for the duration of the illness or until symptoms subside.
Review of the CDC Multidrug-resistant organisms (MDRO) Management Last Reviewed: November 5, 2017, revealed for relatively healthy residents (e.g., mainly independent) make sure that gloves and gowns are used for contact with uncontrolled secretions, pressure ulcers, draining wounds, and ostomy tubes/bags. For ill residents (e.g., those totally dependent upon healthcare personnel for healthcare and activities of daily living) and for those residents whose infected secretions or drainage cannot be contained, use Contact Precautions in addition to Standard Precautions.
Record review revealed the resident has a colostomy (an opening for the colon, or large intestine, through the abdomen) bag on his/her left side.
Record review of the COC dated 9/9/2023 revealed the resident is documented as having an adverse reaction to vancomycin (antibiotic) resulting in the resident developing C-Diff in August of 2022.
Record review of the COC revealed the resident is currently receiving intravenous vancomycin for osteomyelitis and oral vancomycin for the prophylactic treatment for C-Diff.
Review of the physician visit note dated 9/14/2023 revealed the resident has a decolonized or an active problem of Clostridioides Difficile Colitis (C-Diff).
Review of the Nurse practitioner's progress note dated 9/20/2023 revealed the resident has a decolonized or an active problem of Clostridioides Difficile Colitis (C-Diff).
Record review of the progress note dated 9/16/2023 revealed the resident had an ostomy output of 550 milliliters (mL) of stool.
Record review of a progress note dated 9/19/2023 revealed that the resident had loose stool from his/her ostomy.
Record review revealed the resident complained of gastrointestinal upset/nausea on the following days:
9/16/2023
9/17/2023
9/18/2023
9/19/2023
9/20/2023
Review of the resident's bowel movement documentation revealed that the resident had 5 loose stools and 10 putty like stools between 9/13/2023 and 9/20/2023.
During a surveyor observation on 9/18/2023 it was revealed the resident was on contact precautions.
During a surveyor observation on 9/19/2023 it was revealed the resident was no longer on precautions.
During a surveyor interview on 9/19/2023 at 1:10 PM with Licensed Practical Nurse, Staff E, she revealed the resident was removed from contact precautions.
During a surveyor interview on 9/21/2023 at 8:40 AM with Registered Nurse, Staff G, revealed that the stool is emptied from the ostomy bag by the nursing assistants into the toilet. She further revealed that the nurse provides care to the area and changes the appliance.
Review of CENTER FOR EPIDEMIOLOGY & INFECTIOUS DISEASES. Guidelines for the Management of C. Difficile in RI Long Term Care Facilities (2007) revealed to discontinued contact precautions follow up testing should not be done; patients may remain colonized with toxin-producing strains after recovery. Criteria for discontinuing precautions should include the absence of diarrhea and a return to usual bowel pattern. Continue all precautions diligently until diarrhea ceases.
During a surveyor interview on 9/21/2023 at 10:03 AM with the Infection Preventionist, she revealed she was unaware the resident had a history of C-diff. She further acknowledged that the resident is having loose stool related to his/her ostomy status with additional complaints of nausea. Furthermore, she was unable to provide evidence that the facility investigated and determined the resident's infectious status. Lastly, the facility was unable to provide evidence that they maintained an infection prevention and control program to help prevent the transmission of communicable diseases and infections.
CONCERN
(E)
Potential for Harm - no one hurt, but risky conditions existed
Deficiency F0658
(Tag F0658)
Could have caused harm · This affected multiple residents
Based on record review and staff interview, it has been determined that the facility failed to ensure that services provided meet professional standards of quality for 1 of 4 residents reviewed relati...
Read full inspector narrative →
Based on record review and staff interview, it has been determined that the facility failed to ensure that services provided meet professional standards of quality for 1 of 4 residents reviewed relative to wound assessments and following physician orders for skin checks, Resident ID #36.
Findings are as follows:
A. Record review revealed that the resident was admitted to the facility in December of 2022 with a diagnosis including, but not limited to, cellulitis of the right lower extremity.
Review of a care plan for skin integrity revealed an intervention dated 12/20/2022 to conduct systemic skin inspections weekly, as needed, and document the findings.
Review of a physician's order dated 8/9/2023 states, Skin Examination Report to RN [Registered Nurse] and document in Medical Record if new skin condition is identified. Weekly every Tuesday evening.
Record review failed to reveal evidence that skin examinations were completed as ordered on the following dates 8/29, 9/5, 9/12 and 9/19/2023. This indicates that skin examinations had not been completed for 4 consecutive weeks.
During a surveyor interview on 9/20/2023 at 1:17 PM with the Interim Director of Nursing Services (DNS) she acknowledged the 4 weeks of missing skin assessments per the care plan. Additionally, she was unable to provide evidence that the skin checks were performed per the physician's order.
B. According to the Wound Care Education Institute, 2020, wound care documentation should be carried out weekly including type of wound, measurements, type of tissue, symptoms of infection, presence of drainage, wound edges, pain, and current treatment.
Review of a care plan for skin integrity revealed the resident has a hematoma to his/her right posterior leg that opened on 7/6/2023.
Review of the September 2023 Treatment Administration Record revealed a physician's order for wound care for his/her right lower extremity to include cleanse with normal saline, followed by Vaseline impregnated gauze to wound bed followed by ABD pad (Abdominal pad used for heavily draining wounds) and kling wrap daily.
Review of a progress note dated 8/1/2023 at 3:01 PM revealed the resident and family had decided to go to a wound care center outside of the facility.
Record review failed to reveal evidence of weekly documentation of wound measurements, type of tissue, presence of drainage or wound edges.
Record review revealed only a weekly plan to include treatment orders and follow up appointments.
During a surveyor interview on 9/20/2023 at 1:17 PM with the Interim DNS she revealed that the resident goes out to the wound clinic weekly. She failed to provide evidence of weekly wound documentation to include wound measurements, type of tissue, presence of drainage, or wound edges in the resident's medical record.
CONCERN
(E)
📢 Someone Reported This
A family member, employee, or ombudsman was alarmed enough to file a formal complaint
Potential for Harm - no one hurt, but risky conditions existed
Deficiency F0726
(Tag F0726)
Could have caused harm · This affected multiple residents
Based on surveyor obseratio, record review, resident and staff interviews, it has been determined that the facility failed to ensure that all licensed nurses have the specific skill sets necessary to ...
Read full inspector narrative →
Based on surveyor obseratio, record review, resident and staff interviews, it has been determined that the facility failed to ensure that all licensed nurses have the specific skill sets necessary to care for residents' needs for 4 of 5 residents reviewed, relative to changes in condition, Resident ID #s 257, 46, 21, and 15.
Findings are as follows:
Review of a facility in-service titled, Change in Condition, Symptoms, or Signs, held on 6/26/2023, indicated a change in condition, symptoms, or signs include but are not limited to, pain, behavior symptoms, altered mental status, abnormal vital signs, and shortness of breath.
1. Record review revealed Resident ID #257 was admitted to the facility in September of 2023 with diagnoses including, but not limited to, osteomyelitis (infection in the bone), pressure ulcer of the sacral region stage 4 (stage 4 pressure ulcer is the most severe type of pressure ulcer. The skin is severely damaged, and the surrounding tissue begins to die. The underlying muscles or bone may also be damaged), pressure ulcer of the right buttocks stage 4, and pressure ulcer of the left buttocks stage 4.
Review of the care plan dated 9/14/2023 revealed the resident has pain or potential in an alteration in comfort related to a chronic physical disability, right hip infection, and pressure ulcers. It further has interventions which include, but are not limited to, report non-verbal or verbal signs and symptoms of pain promptly to the nurse, medicate prior to therapy and treatment procedures as needed, teach resident to request analgesics/non-pharmacological methods before pain becomes severe and clarify misconceptions about addictions to pain medications.
Record review revealed the resident complained of pain to staff on the following dates:
-9/14/2023
-9/15/2023
-9/17/2023
-9/18/2023
-9/19/2023
-9/20/2023
Record review revealed that on 9/17/2023 the resident refused his/his wound dressings to be changed due to his/her pain.
Record review revealed on 9/18/2023 at 6:22 PM, the facility contacted the nurse practitioner regarding the resident's lab results.
Further record review failed to reveal evidence that pain medication was discussed with the nurse practitioner on 9/18/2023.
During a surveyor interview with Resident ID #257 on 9/18/2023 at 12:15 PM, s/he revealed concerns related to medication management specifically his/her oxycodone timing. The resident revealed that s/he is in pain often and specifically needs his/her oxycodone prior to therapy and dressing changes. S/he further stated staff told him/her to write down his/her concerns and to talk to the doctor on Wednesday.
During a surveyor interview on 9/21/2023 at 8:30 AM with Registered Nurse, Staff I, she revealed that on the morning on 9/18/2023 she advised the resident to write down all of his/her concerns so s/he could address them with the provider when she comes into the facility. Lastly, she revealed she did not contact the physician related to the resident's pain.
During a surveyor interview on 9/22/2023 at 11:58 AM with Registered Nurse Staff H, she acknowledged the resident complained of pain and declined his/her dressing change on 9/17/2023. Additionally, she indicated she did not call they physician to report the resident's pain.
During a surveyor interview with the Physician, Staff F on 9/21/2023 at 10:29 AM, she revealed that the facility did not call her, or the on-call provider related to pain. Additionally, she revealed she would have expected them to call and ask for a one-time dose and then monitor pain.
During a surveyor interview on 9/20/2023 at 1:42 PM, with the Interim Director of Nursing Services (DNS), she revealed that she would have expected the nursing staff to reach out to the provider to report the resident's pain.
2. Record review revealed that Resident ID #46 was admitted to the facility in May of 2022 with a diagnosis including, but not limited to, polyosteoarthritis (present when four or more joints in the body are painful and inflamed).
Review of a care plan dated 5/12/2022 revealed the resident has pain or has the potential for pain due to osteoarthritis. The care plan includes an intervention to report non-verbal or verbal signs and symptoms of pain promptly to the nurse and reassess and adjust the plan to optimize pain relief as needed.
Review of a progress note dated 9/17/2023 at 11:55 AM revealed, signs and symptoms of severe pain starting at lower back and affecting hips and bilateral lower legs. Unable to tolerate HOB [head of bed] elevated and sitting up to transfer. Reports pain subsides when not moving. Medicated with ES [extra strength] Tylenol and tramadol. Son in to visit and expressed concern regarding past back surgeries and requesting XRAYs. Awaiting orders from on call .
Record review failed to reveal evidence of physician notification of increased pain.
During a surveyor interview on 9/21/2023 at 1:01 PM with Licensed Practical Nurse (LPN), Staff D, she revealed that the resident complained of increased pain on Sunday 9/17/2023 and stated that the pain was concerning. Additionally, she revealed that the resident was administered extra strength Tylenol without effect and Tramadol with little effect. Staff D revealed that she reported the resident's pain to the nursing supervisor, but did not report the change in pain to the doctor or request the x-rays that the resident and family requested.
During a surveyor interview on 9/22/2023 at 12:44 PM with Registered Nurse, Staff L, she indicated that there is no real system in place for notifying the physician of a resident's change in condition, and indicated that sometimes things get lost. She further indicated that she is unclear what the process should be when reporting a resident's change in condition, and indicated that some staff notify the nursing supervisor and others notify the physician.
During a surveyor interview on 9/22/2023 at 1:48 PM with Registered Nurse, Staff M, she revealed that she was the nursing supervisor on shift on 9/17/2023 when the resident complained of pain and indicated that she did not report the resident's change in condition to the physician. Additionally, she indicated that she is unclear what the process is for notifying a physician of a resident's change in condition.
During a surveyor interview on 9/22/2023 at 10:44 AM with the Physician, Staff C, he revealed that the staff had not called him on 9/17/2023 to report an increase in back pain causing difficulty sitting up or transferring until 9/21/2023, 4 days following the complaint. He indicated he did not recieve communication regarding increased pain.
During a surveyor interview on 9/21/2023 at 10:32 AM with the Interim Director of Nursing Services she revealed that she would expect the nurse to call the doctor for new orders if a resident complains of increased pain. Additionally, she indicated that a resident's change in condition should be reported to the physician and not to the nursing supervisor.
3. Record review revealed Resident ID #21 was admitted to the facility in March of 2020 with diagnoses including, but not limited to, unspecified dementia and generalized anxiety disorder.
Review of the resident's progress notes revealed a note dated 8/29/2023 which states, Behavior : Pt [patient] awake most of the night, rang call bell [approximately] 20 times during the night, repeated questions 'Am I gonna die', 'Am I gonna live', 'What tests are they running on me'. Intervention: Multiple attempts to answer pt's questions and offer reassurance. Brought pt several glasses of gingerale and adjusted bedding nurmerous [sic.] times. Pt denied pain/ [discomfort]. Response: Behavior continued, pt seemed paranoid, anxious, stating 'Let me see your face, are you telling the truth? I see your eyes, I think that's a lie'.
During a surveyor interview on 9/21/2023 at 10:23 AM, with Registered Nurse, Staff E, she revealed the resident is highly anxious and is very fixated on dying. She indicated these behaviors have been occurring for over a year and staff must constantly reassure him/her that death is not imminent.
During a surveyor interview on 9/21/2023 at 10:53 AM, with the Physician, Staff F, she indicated that the resident has displayed these behaviors in the past, but revealed she was not aware that the behaviors have returned.
During a surveyor interview on 9/21/2023 at 11:13 AM with the Interim Director of Nursing Services, she was unable to provide evidence that the resident's physician was notified of his/her change in condition related to behavioral symptoms.
4. Record review revealed Resident ID #15 was admitted to the facility in June of 2022 with a diagnosis including, but not limited to, left base infiltrate (viral infection that can cause abnormal substances to take residence in the respiratory system).
Record review of a physician's order dated 8/31/2023 reveals Oxygen at 2L [Liter] via [through] NC [nasal cannula] as needed for SOB [shortness of breath] or Pulse Ox less than 90%.
Record review of a progress note dated 9/11/2023 revealed, Activities came to nurses station to inform us that resident was very red and saying [s/he] couldn't breath and oxygen was off of [him/her]. I went and put it back on and took a set of vital signs .Oxygen increased to 3LNC since sats were at 89%. Will pass this on to evening nurse when she comes in shortly.
During a surveyor observations of the resident on the following dates and times revealed s/he was receiving oxygen therapy through his/her nasal cannula at 3 liters per minute:
-9/18/2023 at 9:19 AM
-9/19/2023 at 2:14 PM
-9/20/2023 at 8:12 AM
-9/21/2023 at 9:39 AM
During a surveyor interview with Licensed Practical Nurse, Staff E, on 9/21/2023 at 9:40 AM, she acknowledged that the resident was receiving 3 liters of oxygen via nasal cannula. Additionally, she could not provide evidence that the physician or nurse practitioner were informed of the resident's need for increased oxygen.
During a surveyor interview with the Physician, Staff F on 9/21/2023 at 1:14 PM, she revealed that she would expect the nurse to inform her or the nurse practitioner if there was a change in the resident's condition. Additionally, she acknowledged that she was unaware that the resident required 3 liters of oxygen and would expect herself and/or the nurse practitioner to be notified.
During a surveyor interview with the Interim Director of Nursing Services on 9/21/2023 at 12:43 PM, she revealed she would expect the nurse to have called the physician with the resident's change in oxygen requirements.
Refer to F 697, F 684 and F 695.
CONCERN
(E)
Potential for Harm - no one hurt, but risky conditions existed
Antibiotic Stewardship
(Tag F0881)
Could have caused harm · This affected multiple residents
Based on record review and staff interview, it has been determined that the facility failed to establish an Infection Prevention and Control Program (IPCP) that must include, at a minimum, an antibiot...
Read full inspector narrative →
Based on record review and staff interview, it has been determined that the facility failed to establish an Infection Prevention and Control Program (IPCP) that must include, at a minimum, an antibiotic stewardship program which includes antibiotic use protocols and a system to monitor antibiotic use to ensure that residents who require an antibiotic, are prescribed the appropriate antibiotic for 7 of 8 months reviewed and for 1 of 3 residents reviewed for antibiotic use, Resident ID #36.
Findings are as follows:
1. Review of a facility provided policy titled Antibiotic Stewardship Program dated 1/29/2018, states in part .Purpose .the framework will result in more effective treatment of infections so that resident/patient outcomes are optimized. Appropriate antibiotic use will contribute to minimizing the risk of healthcare-associated infections, benefiting residents/patients, staff, services delivery and clinical outcomes .Policy: the facility antibiotic stewardship program will focus on improving antibiotic use while optimizing the treatment of infections and reducing the risk for possible adverse events associated with antibiotic use .Empirical antimicrobial therapy should be reviewed 48 hours after starting therapy, and no later than the 3rd day of treatment .
Review of a community reported complaint received by the Rhode Island Department of Health on 9/21/2023 alleged that Resident ID #36 was treated with an antibiotic, Invanz (Ertapenem Sodium, antibiotic) for a urinary tract infection (UTI) from 9/2-9/6/2023 and by 9/7/2023 the resident had confusion and hallucinations. Additionally, the allegation revealed that the resident had received the same antibiotic previously with a similar reaction of confusion and hallucinations. The antibiotic had not been added to the antibiotic line list to alert the provider or facility of the adverse reaction.
Review of the Highlights of Prescribing Information for Invanz by Merck Pharmaceuticals revealed rare adverse reactions including, altered mental status such as aggression, delirium, and hallucinations.
Record review revealed that Resident ID #36 was admitted to the facility in May of 2020 with diagnoses including, but not limited to, history of urinary tract infections and dysuria (painful urination).
Review of the February 2023 Medication Administration Record (MAR) revealed the resident received INVanz Solution Reconstituted 1 GM (Ertapenem Sodium, antibiotic) Inject 1 gram [GM] intramuscularly [IM] one time a day for infection for 7 Days from 2/22-2/25/2023.
Review of the progress notes from February 2023 revealed the following:
2/23/2023 at 2:16 PM: .Pt [patient] shows apprehension towards IM antibiotic but allowed to be given on L [left] upper arm .
2/26/2023 at 2:09 AM: Socially Inappropriate/Disruptive: Noisiness/ Screaming. Resisted Care: Resisted ADL [activities of daily living] care. Paranoid Behaviors: Suspiciousness/ Fearfulness. Paranoid Behaviors: Hallucinations -Details of hallucinations: Seeing children in room. stated that 'they came out of [his/her] gut' calling out names and yelling hello .
2/26/2023 at 5:33 AM: Pt refusing care this am. Insisting on sitting on side of bed. Demanding to get in chair but when approached to assist refuses assistance. Pt hallucinating 'bats all over [his/her] room and two babies sitting on the end of [his/her] bed' .
2/26/2023 at 8:46 AM: Res [resident] continues with hallucinations this morning: Cats and dogs in room and two babies on the dresser. Called placed to covering MD, [name redacted], rec'd [received] n.o. [new order] .D/C'd [discontinued] Invanz.
2/27/2023 at 3:14 AM authored by the Physician Staff C: Patient was reported to have some hallucination. Invanz IM discontinued .
Record review of the September 2023 MAR revealed the resident received INVanz Solution Reconstituted 1 GM (Ertapenem Sodium) Inject 1 gram intramuscularly in the morning for UTI for 5 Days from 9/2 throough 9/6/2023.
Review of the progress notes from September 2023 revealed the following:
9/8/2023 at 6:16 PM: Spoke with daughter [name redacted] about concerns of her [parent] being so confused and being alarmed there is no intervention being done about this.
9/10/2023 at 8:18 AM: Resident very restless, trying to get oob [out of bed] multiple times stating [s/he] wants to walk to the bathroom, also that [s/he] is going to the hospital for a test. staff tried to reorient and redirect [him/her] to stay in bed as [s/he] cannot ambulate the way [s/he] thinks [s/he] can, attempts unsuccessful.
During a surveyor interview on 9/22/2023 at 11:10 AM with Licensed Practical Nurse (LPN), Staff D, she revealed that the resident was on Invanz for a urinary tract infection and was having bizarre hallucinations such as, his/her grandchild being under his/her bed, talking to the ceiling and to people that were not there. Additionally, Staff D revealed that the resident appeared to be suffering severe mental anguish and distress. Staff D revealed that she had remembered this behavior once before during another treatment for a UTI and when she looked up the medication, s/he had also been on Invanz at that time.
Review of the facility provided Antibiotic Stewardship Line Listing for 2023 failed to reveal evidence this resident was listed as receiving INVanz for the month of February 2023 and that the resident had an adverse reaction to the medication. This resulted in the resident receiving INVanz in September of 2023 and experiencing an increase in hallucinations, an adverse reaction for a second time.
Record review failed to reveal evidence that the facility listed the resident on the antibiotic line list for the month of September 2023 with Invanz documented as an adverse reaction.
During a surveyor interview on at 1:09 PM with the Interim Director of Nursing Services, she was unable to provide evidence that the facility provided an adequate antibiotic stewardship program that focused on improving antibiotic use while reducing the risk for possible adverse events related to this resident.
2. Review of the antibiotic stewardship monthly records failed to reveal complete documentation of tracking information for the months of January, February, March, April, May, June, August, and September 2023, which included, diagnostic tests including but not limited to laboratory results, x-ray, cultures, and test results to ensure the appropriate antibiotics are prescribed. Further review failed to reveal a system for monitoring or reviewing each resident's response to antibiotics.
During a surveyor interview on 9/21/2023 at 9:57 AM with the Infection Preventionist, she failed to reveal evidence of completed documentation regarding antibiotic stewardship.
CONCERN
(E)
Potential for Harm - no one hurt, but risky conditions existed
Deficiency F0883
(Tag F0883)
Could have caused harm · This affected multiple residents
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on record review and staff interview, it has been determined that the facility failed to ensure the resident's medical rec...
Read full inspector narrative →
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on record review and staff interview, it has been determined that the facility failed to ensure the resident's medical record includes documentation that the resident either received or did not receive the pneumococcal vaccination due to medical contraindications or refusal, for 5 of 8 residents reviewed, Residents ID #'s 14, 15, 21, 30, and 40.
Findings are follows:
According to the State Operations Manual Appendix PP - Guidance to Surveyors for Long Term Care Facilities, Revised 2/3/2023 states in part, .The resident's medical record includes documentation that indicates, at a minimum, the following: .That the resident either received the pneumococcal immunization or did not receive the pneumococcal immunization due to medical contraindication or refusal .
According to the Centers for Disease Control and Prevention (CDC) pneumococcal vaccination is recommended for all adults 19 through [AGE] years old who have certain chronic medical conditions or are 65 years or older who have only received PPSV23 [23 vaccination], the PVC15 [type of pneumococcal conjugate vaccine] or PVC20 [type of pneumococcal conjugate vaccine] dose should be administer at least one year after the most recent PPSV23 vaccination. For adults 19 through [AGE] years old who have certain chronic medical conditions who have only received PVC13 [type of pneumococcal conjugate vaccine], give 1 dose of the PCV20 at least 1 year after PCV13 or give 1 dose of PPSV23 at least 8 weeks after PCV13. For adults 65 years or older who have only received PVC13 [type of pneumococcal conjugate vaccine], give PPSV23 or PCV20 as previously recommended.
Record review of the facility's policy titled Pneumoccal Vaccination (Resident) states in part, .Immunization against the pneumococcal virus will be documented by the facility for each resident per ACIP [Advisory Committee on Immunization Practices] Guidelines. Documentation of immunization will be placed in the individual's record at the facility. If a resident is not immunized, the reason will be documented .
1. Record review of Resident ID #14 revealed the resident was admitted to the facility in September of 2019. Record review of the resident's immunization records failed to reveal evidence that the PPSV23 or PCV20 was offered, received, or declined.
2. Record review of Resident ID #15 revealed the resident was initially admitted to the facility in June of 2022. Record review of the resident's immunization records failed to reveal evidence that the PPSV23 or PCV20 was offered, received, or declined.
3. Record review of Resident ID #21 revealed the resident was admitted to the facility in March of 2020. Record review of the resident's immunization records failed to reveal evidence that the PPSV23 or PCV20 was offered, received, or declined.
4. Record review of Resident ID #30 revealed the resident was admitted to the facility in September of 2021. Record review of the resident's immunization records failed to reveal evidence that the PPSV23 or PCV20 was offered, received, or declined.
5. Record review of Resident ID #40 revealed the resident was admitted to the facility in November of 2020. Record review of the resident's immunization records failed to reveal evidence that the PPSV23 or PCV20 was offered, received, or declined.
During a surveyor interview with the Infection Preventionist on 9/21/2023 at 11:43 AM, she was unable to provide evidence that Resident ID #s 14, 15, 21, 30, and 40 medical records included documentation that indicates, at a minimum if the residents either received the pneumococcal immunization or did not receive the pneumococcal immunization due to medical contraindication or refusal.
During a surveyor interview with the Interim Director of Nursing Services on 9/21/2023 at 1:56 PM, she was unable to provide evidence that the above residents were offered, received, or declined the second pneumococcal vaccine.